CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
4.2 NOK
-0.09 (-2.1%)
CONTX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. CONTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CONTX is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
CONTX has a Return On Assets of 7.66%. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
Looking at the Return On Equity, with a value of 10.25%, CONTX is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.96%, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 9.28%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
With a decent Profit Margin value of 7.86%, CONTX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Profit Margin of CONTX has grown nicely.
CONTX's Operating Margin of 9.33% is fine compared to the rest of the industry. CONTX outperforms 63.64% of its industry peers.
CONTX's Operating Margin has improved in the last couple of years.
The Gross Margin of CONTX (97.46%) is better than 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
Compared to 1 year ago, CONTX has a worse debt to assets ratio.
2.2 Solvency
CONTX has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
CONTX has a Debt to FCF ratio of 1.49. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
CONTX's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. CONTX outperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.08%
2.3 Liquidity
A Current Ratio of 4.12 indicates that CONTX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.12, CONTX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
A Quick Ratio of 4.07 indicates that CONTX has no problem at all paying its short term obligations.
CONTX's Quick ratio of 4.07 is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
CONTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.32%, which is quite good.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
The Revenue has grown by 12.19% in the past year. This is quite good.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
The Earnings Per Share is expected to decrease by -13.34% on average over the next years. This is quite bad
The Revenue is expected to decrease by -1.19% on average over the next years.
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.13, the valuation of CONTX can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CONTX indicates a rather cheap valuation: CONTX is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.39. CONTX is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for CONTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CONTX is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CONTX.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.58 | ||
| EV/EBITDA | 12.33 |
4.3 Compensation for Growth
CONTX has an outstanding profitability rating, which may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -35.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
Compared to an average industry Dividend Yield of 2.30, CONTX pays a better dividend. On top of this CONTX pays more dividend than 81.82% of the companies listed in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
OSL:CONTX (12/19/2025, 7:00:00 PM)
4.2
-0.09 (-2.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap324.95M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (-2.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)-104.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.52%
Revenue NY rev (3m)-11.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | N/A | ||
| P/S | 2.5 | ||
| P/FCF | 50.58 | ||
| P/OCF | 21.81 | ||
| P/B | 3.26 | ||
| P/tB | 3.36 | ||
| EV/EBITDA | 12.33 |
EPS(TTM)0.46
EY10.95%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.08
FCFY1.98%
OCF(TTM)0.19
OCFY4.58%
SpS1.68
BVpS1.29
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.08%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 8 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 7 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.